Boston Metal Wins S&P Global Platts Global Metals Award

4 years ago

Winners announced in London, UK BOSTON--(BUSINESS WIRE)--Boston Metal won the New Technology for the Metals and Mining Industry award at…

Boston Metal Wins S&P Global Platts Global Metals Award

4 years ago

Winners announced in London, UK BOSTON--(BUSINESS WIRE)--Boston Metal won the New Technology for the Metals and Mining Industry award at…

Graphene & Solar Technologies New Shareholder Letter & Update

4 years ago

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--(OTC: GSTX) Graphene & Solar Technologies Limited, releases Shareholder Letter & Company Update. Acquisition of high-tech �Thin-Film�…

Graphene & Solar Technologies New Shareholder Letter & Update

4 years ago

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--(OTC: GSTX) Graphene & Solar Technologies Limited, releases Shareholder Letter & Company Update. Acquisition of high-tech �Thin-Film�…

4 years ago

REQUIRE trial results published in Hypertension Research journal and simultaneously presented at Japanese Society of Hypertension (JSH) 43rd Annual Meeting…

4 years ago

REQUIRE trial results published in Hypertension Research journal and simultaneously presented at Japanese Society of Hypertension (JSH) 43rd Annual Meeting…

Graphene & Solar Technologies New Shareholder Letter & Update

4 years ago

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--(OTC: GSTX) Graphene & Solar Technologies Limited, releases Shareholder Letter & Company Update. Acquisition of high-tech �Thin-Film�…

Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a Novel TCR-Based T Cell Therapy Company and TIO Bioventures Portfolio Company

4 years ago

Combination brings an additional therapeutic modality into Treadwell�s growing pre-clinical pipeline of first in class agents and proprietary platforms Initial…

4 years ago

REQUIRE trial results published in Hypertension Research journal and simultaneously presented at Japanese Society of Hypertension (JSH) 43rd Annual Meeting…

Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a Novel TCR-Based T Cell Therapy Company and TIO Bioventures Portfolio Company

4 years ago

Combination brings an additional therapeutic modality into Treadwell�s growing pre-clinical pipeline of first in class agents and proprietary platforms Initial…

Show more Posts
Show previous Posts